Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a version update of the page's underlying system. This is a maintenance change and does not modify the study details or other substantive content.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page shows a new Revision tag: v3.6.2, replacing the previous v3.6.0. This indicates a minor software or formatting update to the page rather than a change to the trial details.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded a 'No longer looking for participants' notice indicating recruitment has closed. Introduced new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updated header formatting (removal of the 'Intervention / Treatment' variant) along with a revision label change to Revision: v3.6.0 from v3.5.5.SummaryDifference0.4%

- Check39 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a minor update to the page's revision tag.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a backend update to the study record. This change does not modify the visible study details or content on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page's revision/version label updated from v3.5.2 to v3.5.3. This reflects a small update to the page's metadata and does not change the visible study details.SummaryDifference0.0%

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.